Envista Holdings (NVST) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jul 03 2026 to Jun 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Envista Holdings Corporation  (NYSE: NVST)

Envista Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Envista Holdings in the second quarter 2026?
Envista Holdings Corporation achieved a return on average equity (ROE) of 3.08 % in its second quarter 2026, this is above NVST's average return on equity of -1.92%.
Envista Holdings Corporations equity during the 12 months ending in the second quarter 2026 are valued at $3 billion

ROE has advanced compared to 2.18% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 55 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2154 to 2171.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter		 (Jun 27 2025)
II. Quarter
Y / Y Equity Change -2 % 1.43 % 5.84 % 0.51 % -
Y / Y Net Income Change 103.41 % 115 % 2641.67 % - -
Net Income (TTM) in Millions 95 68 47 15 54
Return On Equity (TTM) 3.08 % 2.18 % 1.52 % 0.5 % 1.77 %
NVST's Total Ranking # 2171 # 2154 # 1651 # 1976 # 1892
Equity (TTM) in Millions 3,076 3,080 3,106 3,088 3,139
Seq. Equity Change -0.1 % -0.86 % 0.59 % -1.62 % 3.39 %
Seq. Net Income Change 38.76 % 17.63 % - - 46.67 %

Back to NVST Management Effectiveness >> NVST's 5 Years Annual ROE >> Compare NVST ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 56
Sector # 175
Overall # 2171

Return On Equity Statistics
High Average Low
9.5 %
-1.92 %
-37.41 %
(Oct 01 2021)   (Mar 28 2025)





NVST Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 3,106 2,935 4,174 4,207 4,058
Y / Y Equity Change 5.84 % -29.69 % -0.78 % 3.67 % 9.06 %
Net Income in Millions 47 -1,119 -100 243 341
Y / Y Net Income Change - - - -28.6 % 922.52 %
Return On Equity 1.51 % -38.12 % -2.4 % 5.78 % 8.39 %

Back to NVST Management Effectiveness >> NVST's 5 Years Annual ROE >> Compare NVST ROE to its Competitors




Annual Roe Comment
In 2025 ROE improved to 1.51 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NVST's' Return on Equity at Yahoo Finance
NVST's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NVST's Competitors
Subscribers only: Roe for Envista Holdings's Suppliers
Subscribers only: Return On Equity for NVST's Customers




Companies with similar Return On Equity at Jul 03 2026, within Healthcare Sector ROE
Corcept Therapeutics Inc  8.27 %
Integer Holdings Corporation  7.43 %
Pacific Health Care Organization Inc  7.42 %
Vericel Corporation  6.91 %
The Cooper Companies Inc   6.90 %
Siga Technologies Inc  6.74 %
Merck and Co Inc   6.59 %
Zimmer Biomet Holdings Inc   6.36 %
National Vision Holdings Inc   5.71 %
Conmed Corporation  5.51 %
Pfizer Inc  4.91 %
Privia Health Group Inc   4.23 %
Becton Dickinson And Company  3.79 %
Alkermes Plc   3.72 %
Lifemd Inc   3.47 %
Lifestance Health Group Inc   3.39 %
Revvity Inc  3.27 %
Bio rad Laboratories Inc   3.15 %
Envista Holdings Corporation  3.08 %
Immucell Corporation  2.68 %
Surgery Partners Inc   2.63 %
Mimedx Group Inc   2.61 %
Cormedix Inc   2.18 %
Atricure Inc   2.14 %
Pacira Biosciences inc   2.13 %
Warby Parker Inc   2.06 %
Repligen Corp  1.98 %
Arvinas Inc   1.91 %
Waters Corporation  1.88 %
Omada Health Inc   1.84 %

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.